DCF Valuation: The Stock Market Sanity Check For most

New Post Public Reply Private Reply Replies (0) Message Board
NITE

DCF Valuation: The Stock Market Sanity Check
For most people, discounted cash flow (DCF) valuation seems like a form of financial black art, best left to Ph.D.s and Wall Street technical wizards. DCF intricacies do involve complex math and financial modeling, but if you understand the basic concepts behind DCF, you can perform "back-of-the-envelope" calculations to help you make investment decisions or value small businesses. This article, will discuss a few practical applications.

DCF Usages
Let's begin with a brief overview. DCF is a valuation method that can be used for privately-held companies. It projects a series of future cash flows, EBITDA or earnings and then discounts for the time value of money, typically using the company's own weighted average cost of capital (WACC) over a period of five to 10 years. The sum of all future discounted flows is the company's present value. Professional business appraisers often include a terminal value at the end of the projected earnings period, and they also may apply discounts for small-company risk, lack of liquidity or shares representing a minority interest in the company.

An Acid Test for Valuing a Public Stock
DCF is a blue-ribbon standard for valuing privately-held companies; it can also be used as an acid test for publicly-traded stocks . Public companies in the United States may have P/E ratios (determined by the market) that are higher than DCF. This is especially true of smaller, younger companies with high costs of capital, and uneven or uncertain earnings or cash flow. But it also can be true of large, successful companies with astronomical P/E ratios.

For example, let's do a simple DCF test to check whether Apple stock was fairly valued at a given point in time. During June of 2008, Apple had a market capitalization of $150 billion. The company was generating operating cash flow of around $7 billion per year and we'll assign a WACC of 7% to the company, because it is financially strong and can raise equity and debt capital inexpensively. We'll also assume that Apple can increase its operating cash flow by 15% per year over the 10-year period, a somewhat aggressive assumption because few companies are capable of sustaining such high growth rates over lengthy periods. On this basis, DCF would value Apple at a market capitalization of $106.3 billion, 30% below its stock market price at the time. In this case, DCF provides one indication that the market may be paying too high of a price for Apple common stock. Smart investors might look to other indicators, such as inability to sustain cash flow growth rates in the future, for confirmation.

The Importance of WACC on Stock Market Valuations
Doing just a few DCF calculations demonstrates the link between a company's cost of capital and its valuation. For large public companies (such as Apple), the cost of capital tends to be somewhat stable. But for small companies, this cost can fluctuate significantly over economic and interest rate cycles. The higher a company's cost of capital, the lower its DCF valuation will be. For the smallest companies (below about $500 million in market cap), DCF technicians may add a "size premium" of 2-4% to the company's WACC to account for extra risk.

During the credit crunch of 2007 and 2008, the cost of capital for the smallest public companies soared as banks tightened lending standards. Some small public companies that could tap bank credit at 8% in 2006 suddenly had to pay 12-15% to hedge funds for increasingly-scarce capital. Using simple DCF valuation, let's see what the impact of increasing WACC from 8% to 14% would be on a small public company with $10 million in annual cash flow and projected annual cash flow growth of 12% over a 10-year period.
Net present value of the company @ 8% WACC $143.6 million
Net present value of the company @ 14% WACC $105.0 million
Decline in net present value $ $38.6 million
Decline in net present value % 26.9%

Based on the higher cost of capital, the company is valued at $38.6 million less, representing a 26.9% decline in value.

Building a Company's Value
If you are building a small company and hope to sell it one day, DCF valuation can help you focus on what is most important - generating steady growth on the bottom line. In many small companies, it's difficult to project cash flow or earnings years into the future, and this is especially true of companies with fluctuating earnings or exposure to economic cycles. A business valuation expert is more willing to project growing cash flows or earnings over a lengthy period when the company has already demonstrated this ability.

Another lesson taught by DCF analysis is to keep your balance sheet as clean as possible by avoiding excessive loans or other forms of leverage. Awarding stock options or deferred compensation plans to a company's top executives can strengthen a company's appeal to attract quality management, but it can also create future liabilities that will increase the company's cost of capital.

The Bottom Line
DCF valuation isn't just financial rocket science. It also has practical applications that can make you a better stock market investor because it serves as an acid test of what a public company would be worth if it were valued the same as comparable private companies. Astute, value-minded investors use DCF as one indicator of value, and also as a "safety check" to avoid paying too much for shares of stock, or even a whole company.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 4

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Full-Life's FL-020 Shows Promise for Prostate Cancer

Updated Category News Views 3

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

Continue Reading
HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
AHN Launches Cancer Screenings at Work; Dollar Bank First

Updated Category News Views 35

Pioneering Workplace Cancer Screening Initiative In a move that could redefine preventive healthcare, Allegheny Health Network (AHN) Cancer Center is taking cancer screenings right to the workplace. This initiative isn't just a new gimmick—it's a smart pivot in delivering healthcare where it's most convenient for employees. Here's looking at you, Dollar Bank, for being...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 0

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Corgi Invest Shakes Up Bond ETFs with Low Fees

Updated Category News Views 4

A Different Breed of Bond ETFs Well, folks, when you thought the ETF scene couldn't get any more crowded, Corgi Invest pops in with a pack of 14 new bond ETFs, barking up the low-expense tree like there's no tomorrow. They've dropped these puppies into the market with fees starting as low as 0.02%, aiming to take a bite out of their pricier rivals. The Alpha of Low-Cost...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 6

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Data Center Cooling Market to Hit $1B by 2033

Updated Category News Views 3

The Heat's On: Immersion Cooling Fluid Market Booms Kicking off with numbers straight out of the gate, data center immersion cooling fluids are gearing up for a wild ride. From just $0.23 billion back in 2026, this market is on a blitz to hit a whopping $1.06 billion by 2033. We're talking a hefty 24.8% compound annual growth rate. That's no small shakes. Race for Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

United Therapeutics: Understanding Market Sentiment and Trends

Updated Category News Views 392

Market Sentiment Towards United Therapeutics United Therapeutics (NYSE: UTHR) has seen a notable increase in its short percent of float, rising to 7.82% since the last report. Currently, there are approximately 2.24 million shares sold short, equating to 6.62% of all regular shares available for trading. This trend indicates a growing cautious stance among some investors,...

Continue Reading
Canoe EIT Income Fund Reveals Monthly and Quarterly Distributions

Updated Category News Views 126

Canoe EIT Income Fund’s Distribution Announcements In the ever-evolving landscape of investment funds, the Canoe EIT Income Fund has made significant waves with its recent distribution announcements. The Fund, expertly managed and one of Canada’s premier closed-end investment opportunities, is prepared to offer a monthly distribution amounting to $0.10 per unit. This...

Continue Reading
ADMA Investors Evaluate Class Action Amidst Allegations

Updated Category News Views 9

Securities Fraud Allegations Cast Shadow Over ADMA Well, here we are again, wading through another mess in the biopharma world. This time, it's ADMA Biologics (NASDAQ: ADMA) in the spotlight, and not for their groundbreaking treatments. Nope, this one's about securities fraud allegations and, boy, do investors need to brace themselves. You got Berger Montague PC, those...

Continue Reading
Market Shifts: Navigating the Latest Trends in Trading

Updated Category News Views 266

Indices: An Overview of Uncertain Factors US equity index futures are stabilizing following a session marked by a remarkable rebound from previous lows, leading to higher closes for various indices. The S&P 500 rose by 0.4%, while the Nasdaq 100 surged up 0.7%, and the Dow 30 saw an increase of 0.5%. Notably, the small-cap Russell 2000 experienced the most significant...

Continue Reading
Primech A&P: A Trailblazer in Facility Management Excellence

Updated Category News Views 150

Primech A&P Achieves Prestigious Recognition in Facility Management With great pride, Primech Holdings Limited celebrates a significant milestone achieved by its subsidiary, Primech A&P Pte. Ltd. This notable recognition, the ASEAN Public Toilet Award, was presented in honor of Primech A&P's incredible management and upkeep of public facilities at Newton Food Centre....

Continue Reading